|
US4968507A
(en)
|
1984-06-20 |
1990-11-06 |
Merck & Co., Inc. |
Controlled porosity osmotic pump
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
SG47101A1
(en)
|
1992-07-31 |
1998-03-20 |
Us Bioscience |
Crystalline amifostine compositions and methods for the preparation and use of same
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
DE69433723T3
(de)
|
1993-02-22 |
2008-10-30 |
Abraxis Bioscience, Inc., Los Angeles |
Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
WO1999018937A1
(en)
|
1997-10-16 |
1999-04-22 |
Merck & Co., Inc. |
New cyclobenzaprine composition
|
|
DE69904465T2
(de)
|
1998-05-14 |
2003-10-02 |
Alza Corp., Mountain View |
Therapie von depressionen
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
JP2003506484A
(ja)
|
1999-08-13 |
2003-02-18 |
ベラ・ファーマシューティカルズ・インコーポレイテッド |
非常に低用量のシクロベンザプリンを使用する睡眠障害の処置または予防するための組成物使用
|
|
IL147778A0
(en)
|
1999-08-13 |
2002-08-14 |
Vela Pharmaceuticals Inc |
Pharmaceutical compositions containing cyclobenzaprine
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
WO2001089476A1
(en)
|
2000-05-19 |
2001-11-29 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
|
NZ532583A
(en)
|
2001-11-05 |
2006-12-22 |
Krele Pharmaceuticals |
Compositions and methods for increasing compliance using aldehyde dehydrogenase inhibitors ( ALDH ) such as disulfiram and monoamine oxidase B inhibitors ( MAOB ) such as selegiline
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
US7105486B2
(en)
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
|
US7659253B2
(en)
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
US7038085B2
(en)
*
|
2002-10-25 |
2006-05-02 |
Collegium Pharmaceutical, Inc. |
Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
|
|
ES2685436T3
(es)
|
2002-12-09 |
2018-10-09 |
Abraxis Bioscience, Llc |
Composiciones y procedimientos para administración de agentes farmacológicos
|
|
WO2005000334A1
(en)
|
2003-05-29 |
2005-01-06 |
New River Pharmaceuticals, Inc. |
Abuse resistant amphetamine compounds
|
|
MXPA06005019A
(es)
|
2003-11-03 |
2006-07-06 |
Warner Lambert Co |
Nuevos inhibidores de la recaptacion de norpinefrina para el tratamiento de transtornos del sistema nervioso central.
|
|
US20050143350A1
(en)
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
CA2548281C
(en)
|
2003-12-09 |
2013-11-12 |
Medcrystalforms, Llc |
Method of preparation of mixed phase co-crystals with active agents
|
|
KR20130006523A
(ko)
|
2004-02-17 |
2013-01-16 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
|
US8216610B2
(en)
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
|
US7532935B2
(en)
|
2005-07-29 |
2009-05-12 |
Cyberonics, Inc. |
Selective neurostimulation for treating mood disorders
|
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
US20090069267A1
(en)
*
|
2006-01-17 |
2009-03-12 |
Abrams Daniel J |
Central administration of stable formulations of therapeutic agents for cns conditions
|
|
US20080146672A1
(en)
|
2006-12-08 |
2008-06-19 |
Denton Marcia Marye |
Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
|
|
EP2170064A4
(en)
*
|
2007-06-22 |
2010-08-04 |
Merck Sharp & Dohme |
6,5-pyrrolopiperidine tachykinin receptor antagonists
|
|
JP2010534676A
(ja)
*
|
2007-07-23 |
2010-11-11 |
シノシア・セラピューティクス |
心的外傷後ストレス障害の治療
|
|
US20090060983A1
(en)
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
|
EP2601935A1
(en)
|
2007-09-25 |
2013-06-12 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
|
WO2009058950A2
(en)
|
2007-10-30 |
2009-05-07 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
|
|
US20090148532A1
(en)
|
2007-12-06 |
2009-06-11 |
Venkatesh Gopi M |
Preparation of controlled release skeletal muscle relaxant dosage forms
|
|
JP5714910B2
(ja)
|
2008-01-09 |
2015-05-07 |
チャールストン ラボラトリーズ，インコーポレイテッド |
薬学的組成物
|
|
US9314469B2
(en)
|
2008-05-05 |
2016-04-19 |
Tonix Pharma Holdings Limited |
Method for treating neurocognitive dysfunction
|
|
US20100266682A1
(en)
|
2008-12-10 |
2010-10-21 |
Nipun Davar |
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
|
|
US20100247586A1
(en)
|
2009-03-27 |
2010-09-30 |
Andreas Hugerth |
Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
|
|
EP2233134A1
(en)
|
2009-03-27 |
2010-09-29 |
McNeil AB |
Multi-portion intra-oral dosage form with organoleptic properties
|
|
US20110070301A1
(en)
|
2009-09-24 |
2011-03-24 |
Luber Joseph R |
Orally transformable tablets
|
|
HUE037281T2
(hu)
|
2009-11-20 |
2018-08-28 |
Tonix Pharma Holdings Ltd |
Eljárás és készítmény poszt-traumás stressz rendellenesség tüneteinek kezelésére ciklobenzaprin alkalmazásával
|
|
US20110319389A1
(en)
|
2010-06-24 |
2011-12-29 |
Tonix Pharmaceuticals, Inc. |
Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
|
|
JP6355921B2
(ja)
|
2010-09-01 |
2018-07-11 |
トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. |
コカイン嗜癖の治療
|
|
US11998516B2
(en)
|
2011-03-07 |
2024-06-04 |
Tonix Pharma Holdings Limited |
Methods and compositions for treating depression using cyclobenzaprine
|
|
ES2929133T3
(es)
|
2012-06-15 |
2022-11-25 |
Tonix Pharma Holdings Ltd |
Composiciones y métodos para la absorción transmucosa
|
|
MX370021B
(es)
|
2013-03-15 |
2019-11-28 |
Tonix Pharmaceuticals Inc |
Formulaciones eutécticas de clorhidrato de ciclobenzaprina y de clorhidrato de amitriptilina.
|
|
CN107072968B
(zh)
|
2014-09-18 |
2021-01-12 |
通尼克斯制药控股有限公司 |
环苯扎林盐酸盐的低共熔混合物配制剂
|